SCHEMBL1442106

SCHEMBL1442106

N#Cc1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)cc1F.O=C(c1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)cc1)N1CCOCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK6 Q00534 2/20 0.53
▸ HPGD P15428 2/20 0.51
▸ CYP11B1 P15538 2/20 0.49
▸ CYP11B2 P19099 2/20 0.49
▸ EGLN1 Q9GZT9 2/20 0.47
▸ ERN1 O75460 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ KDM1A O60341 2/20 0.45
▸ PIK3CD O00329 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ PIK3CB P42338 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ PIK3CG P48736 1/20 0.44
▸ PRKDC P78527 1/20 0.44
▸ PIK3C3 Q8NEB9 1/20 0.44
▸ EIF4E P06730 1/20 0.43
▸ MKNK1 Q9BUB5 1/20 0.43
▸ MKNK2 Q9HBH9 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ ALOX5AP P20292 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13277399 0.89 CYP11B1 (0.52) CDK6CYP11B1CYP11B2PIK3CDPIK3CA
SCHEMBL12812023 0.88 HPGD (0.62) CDK6HPGDERN1ALDH1A1PIK3CD
SCHEMBL1442373 0.87 HPGD (0.46) CDK6HPGDCYP11B1CYP11B2EGLN1
SCHEMBL1442624 0.84 HPGD (0.68) CDK6HPGDALDH1A1KDM4E
SCHEMBL1441709 0.83 HPGD (0.70) CDK6HPGDALDH1A1KDM4E
SCHEMBL12812039 0.83 HPGD (0.67) CDK6HPGDALDH1A1MKNK1MKNK2
SCHEMBL13276453 0.79 CYP11B1 (0.63) CYP11B1CYP11B2KDM1APIK3CA
SCHEMBL12812391 0.77 HPGD (0.53) CDK6HPGDEGLN1ALDH1A1PIK3CD
SCHEMBL1444098 0.77 HPGD (0.53) CDK6HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL1443289 0.77 LRRK2 (0.48) CDK6HPGDEGLN1ALDH1A1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 — — EP claimed
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO claimed
Send feedback